Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Catha edulis extract, commonly known as khat extract, is a botanical extract derived from the leaves of the *Catha edulis* (khat) plant, an evergreen shrub native to the Horn of Africa and the Arabian Peninsula. The extract contains various active phytochemicals, including the psychostimulant alkaloids cathinone and cathine, as well as tannins, flavonoids, and polyphenolic compounds. It is traditionally chewed for its mild amphetamine-like stimulant effects. In preclinical research, Catha edulis extract has been investigated for its potential antimicrobial properties, demonstrating antibacterial activity against pathogens such as *Neisseria gonorrhoeae*, *Escherichia coli*, and *Staphylococcus aureus* [7016]. It has also been studied for its effects on the central nervous system, cardiovascular system, and potential cytotoxic activity in certain cancer cell lines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Catha edulis extract.